focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead 2vt Regulatory News (BMD)

Share Price Information for Baronsmead 2vt (BMD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 55.50
Bid: 54.00
Ask: 57.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.556%)
Open: 55.50
High: 55.50
Low: 55.50
Prev. Close: 55.50
BMD Live PriceLast checked at -
Baronsmead Second Venture Trust is an Investment Trust

To achieve long-term investment returns for private investors by investing primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of New Shares

20 Nov 2017 11:00

RNS Number : 9690W
Baronsmead Second Venture Trust PLC
20 November 2017
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY JURISDICTION IN WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA.

BARONSMEAD SECOND VENTURE TRUST PLC

20 November 2017

Issue of New Shares pursuant to the Offer for Subscription

On 4 October 2017, Baronsmead Second Venture Trust plc (the "Company") published a prospectus (the "Prospectus") in relation to an offer for subscription to raise up to £24 million (the "Offer"). As announced by the Company on 8 November 2017, the Board of the Company resolved to move the date of the second allotment from 15 November 2017 to 17 November 2017.

The Company announced on 26 October 2017 that it had raised gross proceeds of approximately £13.5 million pursuant to the Offer and accordingly had issued 13,797,365 New Shares under the Offer. Since then the Company has raised additional gross proceeds of approximately £7.1 million. Accordingly the Company has carried out a second allotment of New Shares pursuant to the Offer, issuing 7,350,154 New Shares in aggregate at an issue price of 97.10 pence. The issue price of the second allotment has been calculated by dividing the Company's latest published Net Asset Value of 94.16 pence as at 31 October 2017 by 0.97 in accordance with the pricing formula set out in the Prospectus.

Applications have been made for the New Shares issued pursuant to the Offer to be admitted to the Official List (with a Premium Listing) and to the London Stock Exchange for the New Shares to be admitted to trading on the Main Market. It is expected that Admission will occur and dealing will commence in the New Shares to be issued pursuant to the Offer at 8.00 a.m. on 21 November 2017.

The Board announced on 8 November 2017 that the Offer had been extended and will remain open until 12 noon on 29 December 2017 or until such date as the Offer is fully subscribed or closed by the Directors, being no later than 29 December 2017. Following the second allotment the Company has raised gross proceeds of approximately £20.6 million pursuant to the Offer and there remains approximately £3.4 million of New Shares available for allotment.

It is expected that share certificates and tax certificates in respect of the New Shares will be issued to the relevant Shareholders on or around 27 November 2017.

Total voting rights

Each Ordinary Share has one voting right. Following the second allotment of New Shares pursuant to the Offer, the Company will have 230,185,440 Ordinary Shares in issue (of which 11,693,214 Ordinary Shares are held in treasury). The total number of voting rights in the Company will therefore be 218,492,226 and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

Definitions

Terms defined in the Prospectus have the same meanings in this announcement unless the context requires otherwise.

Further information

For further information please contact.

Michael Probin - VCT investor relations

Livingbridge VC LLP

020 7506 5796

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

The issue and the distribution of this announcement and the Prospectus in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to in this announcement and the Prospectus comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAEFEASFXFFF
Date   Source Headline
24th May 20175:00 pmRNSTransaction in Own Shares
24th May 20177:00 amRNSHalf-year Report
5th May 20174:00 pmRNSNet Asset Value(s)
18th Apr 20173:30 pmRNSNet Asset Value(s)
23rd Mar 20173:01 pmRNSResult of AGM
14th Mar 20179:16 amRNSDirector Declaration
6th Mar 201711:00 amRNSNet Asset Value(s)
2nd Mar 20177:00 amRNSDividend Declaration
6th Feb 201712:00 pmRNSNet Asset Value(s)
19th Jan 201710:00 amRNSNet Asset Value(s)
3rd Jan 20172:00 pmRNSTotal Voting Rights
14th Dec 20164:01 pmRNSTransaction in Own Shares
6th Dec 20164:00 pmRNSNet Asset Value(s)
30th Nov 20162:45 pmRNSIssue of Equity
28th Nov 20161:00 pmRNSNet Asset Value(s)
24th Nov 20162:30 pmRNSPublication of Supplementary Prospectus
17th Nov 20167:00 amRNSNet Asset Value(s)
17th Nov 20167:00 amRNSAnnual Financial Report
8th Nov 20164:36 pmRNSResult of General Meeting
17th Oct 20164:52 pmRNSMerger Update
14th Oct 20163:00 pmRNSNet Asset Value(s)
12th Oct 20163:19 pmRNSDirectorate Change
3rd Oct 20162:50 pmRNSTotal Voting Rights
29th Sep 20165:15 pmRNSTransaction in Own Shares
26th Sep 20164:00 pmRNSNet Asset Value(s)
6th Sep 20163:30 pmRNSNet Asset Value(s)
24th Aug 20167:00 amRNSDividend Declaration
19th Aug 201610:30 amRNSNet Asset Value(s)
19th Aug 20167:00 amRNSHalf-year Report
11th Aug 20165:30 pmRNSProposed Merger
9th Aug 20165:59 pmRNSChange of accounting reference date
1st Jul 201610:17 amRNSTotal Voting Rights
29th Jun 20164:56 pmRNSTransaction in Own Shares
6th Jun 20164:28 pmRNSNet Asset Value(s)
1st Jun 20164:24 pmRNSTransaction in Own Shares
24th May 20165:11 pmRNSNet Asset Value(s)
24th May 20164:53 pmRNSNet Asset Value(s)
12th May 201612:14 pmRNSDividend Declaration
19th Apr 20165:05 pmRNSResult of AGM
1st Apr 20163:16 pmRNSTotal Voting Rights
30th Mar 20165:48 pmRNSTransaction in Own Shares
15th Mar 20165:01 pmRNSChange of Name
15th Mar 20163:42 pmRNSIssue of Equity
11th Mar 20164:49 pmRNSIssue of Equity
10th Mar 20165:03 pmRNSPublication of Supplementary Prospectus
4th Mar 20164:57 pmRNSNet Asset Value(s)
3rd Mar 20165:12 pmRNSResult of General Meeting
2nd Mar 20162:43 pmRNSDirector Declaration
25th Feb 201611:03 amRNSDisclosure of Home Member State
24th Feb 201610:50 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.